The Analysis of ceRNA Networks and Tumor Microenvironment in Endometrial Cancer

2024-1-1

LINC00839 in Human Disorders: Insights into its Regulatory Roles and Clinical Impact, with a Special Focus on Cancer

2024-1-1

Prognostic Significance of KIF-12 Functioning as a Tumour Suppressor in Papillary Thyroid Carcinoma

2024-1-1

Optimal Screening and Detection Strategies for Cervical Lesions: A Retrospective Study

2024-1-1

Hypoxia-responsive gene <i>F3</i> Promotes GBM Cell Proliferation and Migration through Activating NF-κB/p65 Signaling Pathway

2024-1-1

Apolipoprotein L3 inhibits breast cancer proliferation and modulates cell cycle via the P53 pathway

2024-1-1

Capsaicin exerts synergistic pro-apoptotic effects with cisplatin in TSCC through the calpain pathway via TRPV1

2024-1-1

DNA methylation profiling deciphers three EMT subtypes with distinct prognoses and therapeutic vulnerabilities in breast cancer

2024-1-1

Baicalin Induces Gastric Cancer Cell Pyroptosis through the NF-κB-NLRP3 Signaling Axis

2024-1-1

Exploration of radiotherapy strategy for brain metastasis patients with driver gene positivity in lung cancer

2024-1-1

Is robotic surgery beneficial for the treatment of endometrial cancer? A comparison with conventional laparoscopic surgery

2024-1-1

High CD204⁺ tumor-associated macrophage density predicts a poor prognosis in patients with clear cell renal cell carcinoma

2024-1-1

Tripartite motif-containing 28 (TRIM28) expression and cordycepin inhibition in progression, prognosis, and therapeutics of patients with breast invasive carcinoma

2024-1-1

Comprehensive analysis based on glycolytic and glutaminolytic pathways signature for predicting prognosis and immunotherapy in ovarian cancer

2024-1-1

Pan-Cancer Analysis Reveals SOX2 as a Promising Prognostic and Immunotherapeutic Biomarker Across Various Cancer Types, Including Pancreatic Cancer

2024-1-1

IGFBP5, as a Prognostic Indicator Promotes Tumor Progression and Correlates with Immune Microenvironment in Glioma

2024-1-1

Predictive Biomarkers of Immune Checkpoint Inhibitor-Based Mono- and Combination Therapies for Hepatocellular Carcinoma

2024-1-1

Periprostatic Adipose Tissue: A New Perspective for Diagnosing and Treating Prostate Cancer

2024-1-1

Exploring Prognostic Immune Microenvironment-Related Genes in Head and Neck Squamous Cell Carcinoma from the TCGA Database

2024-1-1

Cuproptosis-related genes score and its hub gene GCSH: A novel predictor for cholangiocarcinomas prognosis based on RNA seq and experimental analyses

2024-1-1

Differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma by ultrasonography combined with multiphase enhanced computed tomography

2024-1-1

Relationship Between Resilience, Social Support, Existential Well-Being and Negative Emotions in Cervical Cancer Patients: a Mediation Analysis

2024-1-1

ECT2 promotes the occurrence and is a prognostic biomarker of head and neck squamous cell carcinoma

2024-1-1

N⁶-methyladenosine-modified circ_0006168 promotes epithelial mesenchymal transition via miR-384/STAT3/Snail axis in esophageal squamous cell carcinoma

2024-1-1

NOTCH3 inhibits transcription factor ZEB1 expression and metastasis of breast cancer cells via transcriptionally upregulating miR-223

2024-1-1

Expression and clinical significance of ECHS1 in gastric cancer

2024-1-1

Anoikis-related CTNND1 is associated with immuno-suppressive tumor microenvironment and predicts unfavorable immunotherapeutic outcome in non-small cell lung cancer

2024-1-1

Interplay of Sphingolipid Metabolism in Predicting Prognosis of GBM Patients: Towards Precision Immunotherapy

2024-1-1

CNKSR2 expression is correlated with immune infiltrates in Cervical Cancer as a favorable prognostic factor

2024-1-1

CD206 modulates the role of M2 macrophages in the origin of metastatic tumors

2024-1-1

Integrative Omics Analysis Reveals Metabolic Features of Ground-Glass Opacity-Associated Lung Cancer

2024-1-1

Identification of crucial genes through WGCNA in the progression of gastric cancer

2024-1-1

CSF2 Impairs Nrf2 Signaling through the Akt/Mtor Pathway in the Development of Bladder Cancer

2024-1-1

ACAT1 promotes proliferation and metastasis of bladder cancer via AKT/GSK3β/c-Myc signaling pathway

2024-1-1

Nomograms for Predicting Risk and Survival of Esophageal Cancer Lung Metastases: a SEER Analysis

2024-1-1

Exosomal SOX21-AS1 Regulates EREG by Sponging miR-451a and Promotes the Malignancy of Pancreatic Ductal Adenocarcinoma

2024-1-1

5-Fluorouracil resistant CRC cells derived exosomes promote cancer-associated fibroblasts secreting more CXCL12

2024-1-1

Fluoxetine as a Potential Therapeutic Agent for Inhibiting Melanoma Brain and Lung Metastasis: Induction of Apoptosis, G0/G1 Cell Cycle Arrest, and Disruption of Autophagy Flux

2024-1-1

Metabolic Heterogeneity of Tumor Cells and its Impact on Colon Cancer Metastasis: Insights from Single-Cell and Bulk Transcriptome Analyses

2024-1-1

Exosomes in Bone Cancer: Unveiling their Vital Role in Diagnosis, Prognosis, and Therapeutic Advancements

2024-1-1

Integration of single-cell and bulk RNA sequencing data reveals that CYTOR is a potential prognostic and immunotherapeutic response marker for skin cutaneous melanoma

2024-1-1

Acting mechanism and clinical significance of hsa_circ_0005927 in the invasion and metastasis of gastric cancer

2024-1-1

Prognostic signature and immune efficacy of m¹A-, m⁵C-, m⁶A-, m⁷G-, and DNA methylation-related regulators in hepatocellular carcinoma

2024-1-1

Comprehensive analysis of the clinical significance and molecular mechanism of T-box transcription factor 3 in osteosarcoma

2024-1-1

Ophiopogonin B inhibits migration and invasion in non-small cell lung cancer cells through enhancing the interaction between Axin and β-catenin: Erratum

2024-1-1

Exploring the Mediation Effect of Metabolite Levels on the Association Between Gut Microbiota and HCC: A two-step, two-sample bidirectional Mendelian Randomization

2024-1-1

Treatment of HNSC and pulmonary metastasis using the anti-helminthic drug niclosamide to modulate Stat3 signaling activity

2024-1-1

Synergistic Anti-Tumor Efficacy Achieved by Reversing Drug Resistance through the Regulation of the Tumor Immune Microenvironment with IL-12 and Osimertinib Combination Therapy

2024-1-1

A Novel Signature Based on Angiogenesis-Related Genes Predicts the Prognosis and Immunotherapy Response in HER2-Positive Breast Cancer

2024-1-1

ABO/Rh Blood Group and Cervical Cancer Survival: Results from Our Own and Other Studies

2024-1-1